senior management

News

Final obstacles in front of Pfizer, Seagen merger fall

Pfizer is expecting to close its $43 billion acquisition of antibody-drug conjugate (ADC) pioneer Seagen tomorrow, after receiving all the required regulatory approvals fo

News

Genentech confirms Magargee as permanent CEO

Roche’s Genentech unit has looked internally for its new chief executive, appointing Ashley Magargee to the role following the departure of Alexander Hardy last month.

News

FDA elevates chief scientist Bumpus to the number two role

FDA chief scientist Namandjé Bumpus has been named as principal deputy commissioner, replacing long-serving Janet Woodcock when she steps down early next year.

News

Change at the top at Recipharm as strategy shifts

Swedish contract development and manufacturing organisation (CDMO) Recipharm has appointed former Nestlé Health Sciences’ chief executive Greg Behar as its new CEO, replac

News

FDA’s Janet Woodcock will step down early next year

Janet Woodcock will bring a career at the FDA spanning almost four decades to a close next year, retiring from her current role as principal deputy commissioner of the reg

News

Change at the top at BioMarin as CEO Bienaimé steps down

After 18 years in charge, BioMarin Pharma’s chief executive and chairman, Jean-Jacques Bienaimé, has announced his retirement, with a high-powered replacement already line

Final obstacles in front of Pfizer, Seagen merger fall

Genentech confirms Magargee as permanent CEO

FDA elevates chief scientist Bumpus to the number two role

Change at the top at Recipharm as strategy shifts

FDA’s Janet Woodcock will step down early next year

Change at the top at BioMarin as CEO Bienaimé steps down

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

senior management

Editor's Picks